Continuous v Bolus Infusion of Cefazolin During Ventral Hernia Repair

Status Withdrawn

Clinical Trial Summary

Patients undergoing an elective ventral hernia repair will be randomly assigned to receive either bolus infusion or continuous infusion of the cefazolin as the prophylactic antibiotic. The blood concentrations of unbound cefazolin would be measured in their blood samples and the levels compared within the two groups with respect to their minimal inhibitory concentration (MIC) value.

Clinical Trial Description

Patients who will be undergoing elective ventral hernia repair will be potential candidates for this study. Once identified, the surgical team will approach the participant for consent and inclusion in the study. On the day of surgery, the subjects will be assigned to either the Bolus Group (CB) or Continuous Infusion Group (CI) according to a randomly generated assignment procedure. During the procedure, the dose of prophylactic Cefazolin will be given an hour before surgery and will be administered in accordance to group assignment. Subjects in the CB will receive bolus infusions of Cefazolin every 4 hours till the end of surgery. Subjects in the CI group will receive an initial bolus injection of Cefazolin followed by a continuous infusion till the closure of skin incision. Blood samples will be taken during surgery at t=0, 15, 30 and 60 minutes and every hour following till the end of surgery or 6 hours (whichever comes sooner) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02666365
Study type	Interventional
Source	Milton S. Hershey Medical Center
Contact
Status	Withdrawn
Phase	Phase 4
Start date	March 2018
Completion date	June 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04969302` - Examination of the Effect of Skin Antisepsis With Pre-heated Povidone Iodine on Surgical Site Infections: A Quasi-Experimental Study	N/A
Completed	`NCT02253069` - PHMB-based Antiseptic Use in Full-thickness Surgical Wounds	N/A
Completed	`NCT01472549` - The Skin Prep Study	N/A
Completed	`NCT03685604` - PVP Iodine vs Chlorhexidine in Alcohol for Disinfection of the Surgical Site	Phase 4
Not yet recruiting	`NCT02503904` - Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection	Phase 2/Phase 3
Completed	`NCT01888367` - Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery	Phase 2
Completed	`NCT02619773` - Effect of Mupirocin Dressings Versus Island Dressings on Surgical Site Infections in Elective Colorectal Surgery	N/A
Completed	`NCT01425697` - Eliminate Risk of Cardiac Surgical Site Events	N/A
Terminated	`NCT02799667` - Do Single Use Negative Pressure Dressings Reduce Wound Complications in Obese Women After Cesarean Delivery	N/A
Recruiting	`NCT02436395` - Povidone-iodine and the Normal Saline Cleaning the Incision for the SSIs	N/A
Active, not recruiting	`NCT03402945` - Prevention of Infections in Cardiac Surgery (PICS) Prevena Study	Phase 4
Completed	`NCT01971138` - Review of Surgical Site Infection Registration Routine at Surgery Departments in Sweden and Validation of One of the Used Routines	N/A
Completed	`NCT01949935` - Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting	Phase 3
Completed	`NCT01138852` - Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section	Phase 4
Recruiting	`NCT06378359` - Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
Not yet recruiting	`NCT02012517` - Antibiotic Prophylaxis in Prosthetic Breast Reconstructions	Phase 4
Completed	`NCT01916733` - A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study	N/A
Completed	`NCT03686553` - St. Barbara Specialised Regional Hospital No. 5: Surveillance of Healthcare-Associated Infections
Not yet recruiting	`NCT06043414` - Barbed Suture vs Non-Barbed Closure for Emergency Exploratory Laparotomy RCT	N/A
Completed	`NCT05090657` - Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures	Phase 2